Saturday 21 May 2022
The US Centers for Disease Control and Control (CDC) approved the booster doses for children ages 5 to 11, after its independent vaccine advisors recommended that they receive an additional dose of the Pfizer-Biontech coronavirus vaccine, after receiving the initial vaccination series.
CDC vaccine advisers voted 11 to recommend a booster dose, to one against and one abstention, Thursday. The FDA approved it earlier this week.
The recommendation reads: “A booster dose of the Pfizer-Biontech COVID-19 vaccine is recommended for people aged 5 to 11 years at least 5 months after receiving the initial series of doses, pursuant to an emergency use authorization by the Food and Drug Administration.” , according to CNN.
The CDC’s Advisory Committee on Immunization Practices approved the booster dose for children at least 5 months after they received the first two doses of the vaccine. This will be a third dose for healthy children, and a fourth dose for children who are immunocompromised.
The committee voted in favor of the booster dose after hearing details about Pfizer’s request that the Food and Drug Administration expand age groups for the booster doses.
A decrease in antibody levels was observed in children who received the primary vaccination series, and the booster doses achieved higher antibody levels than was recorded after the primary series.
The company announced that data from its clinical trials showed that the booster dose raised anti-Omicron antibodies 36 times, within this age group.
The company reported that the experiment, which included 4,500 children, between the ages of 5 and 11, did not see any new problems related to safety.
“Overall, the benefits from Covid vaccines still outweigh the risks, as we can see, apart from the age group on which he highlighted, receiving the initial Covid vaccine series remains important,” said Dr Sarah Oliver, Pediatric Infectious Diseases Specialist and Working Group Leader of the Advisory Committee on Immunization Practices. very useful to prevent severe illness and death.”
She added, “It has been shown that booster doses of the COVID-19 vaccine increase protection against the consequences of infection in those 12 years of age and older, and children aged 5 to 11 years may benefit from a booster dose of the COVID-19 vaccine.”